CPT code 0347T covers placement of multiple tantalum beads in bone and acquisition of a two-dimensional image to measure motion, quality, and wear of an implant or prosthesis. This code supports advanced implant surveillance and research-quality assessments of prosthetic performance, with implications for postoperative management, device surveillance, and outcomes measurement nationwide. It matters both clinically—by providing objective data on implant behavior—and administratively, as payers consider coverage for specialized imaging and marker placement linked to device evaluation.

Key payers in the scope of typical coverage discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for marker-assisted implant assessment, typical settings where the service is performed, and what to expect in payer review. The publication outlines benchmarking topics and policy considerations relevant to coverage decisions, coding nuances for operations involving implants, and patterns in utilization when available. Data not available in the input for detailed payer-specific rates, associated taxonomies, and ICD-10 diagnosis mappings is noted for transparency.

This piece provides clinicians, billing professionals, and policy analysts a concise reference to the clinical purpose of CPT code 0347T, the service setting, and the payer landscape to inform coding, billing, and coverage conversations at the national level.